3 myths about prostate cancer

A man in a red t shirt holds a blue ribbon in his right hand and makes a thumbs up with his left while smiling.

What misconceptions do you have about Prostatakrebs? Let’s put your knowledge to the test by debunking three common myths.

MYTH #1: Prostate cancer is a death sentence

According to the Prevent Cancer Foundation’s Früherkennungsumfrage 2025, 39% of respondents said they believe a cancer diagnosis is usually a death sentence.

However, most prostate cancers are slow growing. When found early before the cancer has spread beyond the prostate, the five-year survival rate is close to 100%!

In fact, some prostate cancer diagnoses don’t require immediate treatment. In these cases, you and your health care provider may decide on “active surveillance” with regular follow-ups.

LESEN SIE AUCH | Why ESPN legend Adrian Wojnarowski decided on active surveillance following his prostate cancer diagnosis

In other cases, you may need immediate treatment. Treatment depends on the type and grade of tumor cells, the stage of the cancer and your other medical conditions.

MYTH #2: There’s a one-size-fits-all screening recommendation for prostate cancer

Early detection of prostate cancer can save lives, but there are benefits and risks to screening. Not all prostate cancers require treatment, and treatment can also have risks and side effects. Because of this, the recommendation is to talk with your health care provider about the pros and cons of screening to decide what’s best for you. And even then, the age you start the conversation depends on a few factors.

Start the conversation at:

Age 40+ if you have a strong family history. Wenn mehr als ein naher Verwandter (Elternteil, Kind oder Geschwister) vor dem 65. Lebensjahr an Prostatakrebs erkrankt ist, sprechen Sie mit Ihrem Arzt ab dem 40. Lebensjahr über ein Prostatakrebs-Screening.

Age 45+ if you are Black OR have a family history. Wenn Sie schwarz sind oder einen nahen Verwandten (Elternteil, Kind oder Geschwister) haben, der vor dem 65. Lebensjahr an Prostatakrebs erkrankt ist, sprechen Sie ab dem 45. Lebensjahr mit Ihrem Arzt über ein Prostatakrebs-Screening.

Age 50+ if you’re at average risk. Wenn bei Ihnen ein durchschnittliches Risiko für Prostatakrebs besteht, besprechen Sie die Vor- und Nachteile eines Screenings ab dem 50. Lebensjahr mit Ihrem Arzt.

MYTH #3: I don’t have a family history of prostate cancer, so I don’t need to worry about it

While a family history of prostate cancer is one risk factor, there are others to be aware of. Even without a family history of prostate cancer, if you have family members with BRCA1 or BRCA2 genetic mutations or Lynch syndrome, this increases your risk, too. It’s important to know your complete family health history to get a full picture of your risk. You can also consider genetic testing to better understand your risk.

If you’re Black, you also have an increased risk of prostate cancer. The incidence of prostate cancer is more than 70% higher in Black men than in white men for reasons that remain unclear. This is why it is recommended Black men discuss screening options with a health care provider at an earlier age than people of other races.

LESEN SIE AUCH | How the future of prostate cancer screening could improve health outcomes

Prostate cancer can happen with no family history at all, so everyone—even those at average risk—needs to discuss screening options with a provider.

LESEN SIE AUCH | How genetics affects your cancer risk—and what you can do about it

It’s clear that there are lots of myths and misconceptions, so it’s important to discuss any questions and specific recommendations with your health care provider. With prostate cancer, everyone is different, but informed shared decision making between you and your doctor can help you take charge of your health.